Rochester Regional Health Launches New Genetic Screening Program
Gates, N.Y. — Rochester Regional Health has introduced a genetic screening initiative called GenoWell. This program aims to demonstrate how DNA can influence individual health.
“This is the future of medicine,” remarked Dr. Prad Phatak, who oversees precision medicine at the institution and serves as the primary investigator for GenoWell. He emphasized that the goal is to tailor treatments based on one’s genetic profile, which represents the peak of personalized medicine.
On Monday, medical professionals gathered at Rochester Regional Health’s Elmgrove Park to launch the program. It’s open to adults aged 18 and older, with plans to accommodate up to 100,000 participants at no cost over the next five years.
“Initial findings may indicate if there’s an elevated risk for certain cancers or cardiovascular issues—three key conditions will be analyzed,” explained Heather Bacchetta, the program’s director of precision medicine. She noted that these conditions include hereditary breast and ovarian cancer, Lynch syndrome with a tendency towards colorectal cancer, and hereditary high cholesterol linked to strokes and heart disease. Participants will also learn about their regional ancestry and specific traits like sleep patterns and caffeine sensitivities.
Enrollees will provide a blood sample, and confidential results should be available within two to four weeks, according to Bacchetta. If any concerning issues arise, Rochester Regional Health will step in to provide assistance.
“Individuals with positive outcomes can consult with one of our genetic counselors at no cost to help them understand their results and discuss proactive care options,” she added.
Patient Sheri Nordberg shared her experience, saying, “I did the testing because, honestly, why not? It’s bound to be beneficial for my health.” She found that her results indicated a pattern of heart complications in her family.
“My doctor prescribed cholesterol medication,” she continued. “We had a good discussion about what steps I should take next, including notifying my family. It was straightforward, and I genuinely believe everyone should consider doing it.”
Regarding the safety of health data, Dr. Roberto Vargas, the executive medical director for pathology and laboratory medicine, assured that it’s encrypted and secured. “It’s stored in a protected database; access is strictly regulated,” he noted.
Vargas also underscored that the data collected is intended solely for research purposes, not for marketing. “It’s not for advertisement,” he clarified. “Our focus is on advancing new therapies.”
The initiative also aims to paint a broader picture of health trends within the community. “We have the potential to make a real impact on people’s lives,” Phatak stated. “Many are eager to find out if they face these health risks.”
CLICK HERE to enroll in the program.
